BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1976298)

  • 21. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials.
    Fox RW; Lockey RF; Bukantz SC; Serbousek D
    J Allergy Clin Immunol; 1986 Dec; 78(6):1159-66. PubMed ID: 3097109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic urticaria with a new synthetic antihistamine: astemizole].
    Annunziata M; Aimo Boot D
    G Ital Dermatol Venereol; 1984; 119(5):XVII-XX. PubMed ID: 6150894
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
    Franke W; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hay fever therapy with 2 non-sedating antihistaminics].
    Bäurle G
    Z Hautkr; 1985; 60 Suppl 1():46-9. PubMed ID: 2859713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind study of astemizole and terfenadine in the treatment of perennial rhinitis.
    Boland N
    Ann Allergy; 1988 Jul; 61(1):18-24. PubMed ID: 2898906
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
    Leynadier F; Duarte-Risselin C; Murrieta M
    Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of chronic urticaria with astemizole: a multicenter pediatric study].
    Guinnepain MT
    Allerg Immunol (Paris); 1987 Apr; 19(4):173, 175-6. PubMed ID: 3134034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparative trial of astemizole and terfenadine for the treatment of hay fever.
    Troise C; Voltolini S; Cilli P; Negrini AC
    Allerg Immunol (Paris); 1989 Dec; 21(10):396-8, 400. PubMed ID: 2576206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria.
    Bernstein IL; Bernstein DI
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):37-42. PubMed ID: 3080510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J; Bor S; Blair C
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract]   [Full Text] [Related]  

  • 36. H1-receptor-active histamine not sole cause of chronic idiopathic urticaria.
    Krause LB; Shuster S
    Lancet; 1984 Oct; 2(8408):929-30. PubMed ID: 6148648
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihistamines in the treatment of urticarial disorders.
    Shuster S
    Cutis; 1988 Oct; 42(4A):26-8. PubMed ID: 2903816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of astemizole and chlorpheniramine in dermographic urticaria.
    Krause LB; Shuster S
    Br J Dermatol; 1985 Apr; 112(4):447-53. PubMed ID: 3922395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astemizole, an H1 antagonist, has no additional therapeutic effect in rheumatoid arthritis.
    Chard MD; Crisp AJ
    J Rheumatol; 1991 Feb; 18(2):203-4. PubMed ID: 1673723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.